An assessment of mucosal immunisation in protection against Streptococcus equi ('Strangles') infections in horses.
The ability of mucosally administered antigen to provide protection against Streptococcus equi ('Strangles') infections in horses was examined. First, an enzyme linked immunosorbent assay (ELISA) was developed to detect the immune status of horses to S. equi. This assay was used to select Strangles-naive horses for the study and also to monitor their response to immunisation. Potential vaccine candidates were: (a) orally administered paraformaldehyde killed S. equi; (b) intraperitoneally (IP) administered paraformaldehyde killed S. equi in a non-inflammatory adjuvant; (c) orally administered live avirulent S. equi; (d) orally administered microencapsulated streptococcal M protein. The latter three preparations were first assessed in a rat model, using rate of lung bacterial clearance following intratracheal inoculation of live virulent bacteria as an indication of efficacy. Candidates (a) and (b) were then assessed in an equine model. IP immunisation of horses was shown to effectively induce production of specific antibody in mucosal and systemic sites. Four weeks after initial immunisation, horses were challenged intranasally with live virulent S. equi. Both groups of immunised horses demonstrated partial protection following vaccination. Of the IP immunised horses, only two out of four developed clinical signs of Strangles following live challenge. The orally immunised horses all developed submandibular abscesses containing S. equi. However, none of the immunised horses became as ill as the control horses in terms of fever, anorexia, loss of condition and general malaise.
Wallace
F J
FJ
Department of Pathology, University of Newcastle, N.S.W., Australia.
Emery
J D
JD
Cripps
A W
AW
Husband
A J
AJ
D000284:Administration, Oral; D000818:Animals; D000907:Antibodies, Bacterial / Q000096:biosynthesis; D001428:Bacterial Vaccines / Q000276:immunology*; D004195:Disease Models, Animal; D005260:Female; D006734:Horse Diseases / Q000276:immunology* / Q000517:prevention & control*; D006736:Horses; D007274:Injections, Intraperitoneal; D007413:Intestinal Mucosa / Q000276:immunology* / Q000382:microbiology; D008297:Male; D051379:Mice; D051381:Rats; D011919:Rats, Inbred Strains; D013290:Streptococcal Infections / Q000276:immunology / Q000517:prevention & control* / Q000662:veterinary*; D018502:Streptococcus equi / Q000276:immunology*
D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines